| abstract |
The present application relates to at least two components, component A and component B, for treating and / or preventing a disease: Component A [IRAK4 inhibitory compound of formula (I) as defined herein, Stereomers, enantiomers, metabolites, salts, solvates or solvates of salts]; • Component B [BTK inhibitory compound, or a pharmaceutically acceptable salt thereof]; A combination of components A and B as defined above, wherein one or two of compounds A and B as defined above may be present in a pharmaceutical formulation for simultaneous, separate or sequential administration; For the manufacture of a medicament for the treatment and / or prevention, in particular for the treatment and / or prevention of endometriosis, lymphoma, macular degeneration, COPD, neoplastic diseases and psoriasis. It relates to the use of. [Selection figure] None |